Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Departments of Surgery and Pediatrics and the Epithelial Biology Center, Vanderbilt University School of Medicine, Nashville, Tennessee.
Gastroenterology. 2018 Jun;154(8):2045-2059.e6. doi: 10.1053/j.gastro.2018.03.067. Epub 2018 Apr 12.
Diarrhea is common in infants (children less than 2 years of age), usually acute, and, if chronic, commonly caused by allergies and occasionally by infectious agents. Congenital diarrheas and enteropathies (CODEs) are rare causes of devastating chronic diarrhea in infants. Evaluation of CODEs is a lengthy process and infrequently leads to a clear diagnosis. However, genomic analyses and the development of model systems have increased our understanding of CODE pathogenesis. With these advances, a new diagnostic approach is needed. We propose a revised approach to determine causes of diarrhea in infants, including CODEs, based on stool analysis, histologic features, responses to dietary modifications, and genetic tests. After exclusion of common causes of diarrhea in infants, the evaluation proceeds through analyses of stool characteristics (watery, fatty, or bloody) and histologic features, such as the villus to crypt ratio in intestinal biopsies. Infants with CODEs resulting from defects in digestion, absorption, transport of nutrients and electrolytes, or enteroendocrine cell development or function have normal villi to crypt ratios; defects in enterocyte structure or immune-mediated conditions result in an abnormal villus to crypt ratios and morphology. Whole-exome and genome sequencing in the early stages of evaluation can reduce the time required for a definitive diagnosis of CODEs, or lead to identification of new variants associated with these enteropathies. The functional effects of gene mutations can be analyzed in model systems such as enteroids or induced pluripotent stem cells and are facilitated by recent advances in gene editing procedures. Characterization and investigation of new CODE disorders will improve management of patients and advance our understanding of epithelial cells and other cells in the intestinal mucosa.
腹泻在婴儿(2 岁以下儿童)中很常见,通常是急性的,如果是慢性的,通常由过敏引起,偶尔由感染因子引起。先天性腹泻和肠病(CODEs)是导致婴儿严重慢性腹泻的罕见原因。评估 CODEs 是一个漫长的过程,很少能明确诊断。然而,基因组分析和模型系统的发展增加了我们对 CODE 发病机制的理解。随着这些进展,需要一种新的诊断方法。我们提出了一种新的方法来确定包括 CODEs 在内的婴儿腹泻的原因,该方法基于粪便分析、组织学特征、对饮食改变的反应和基因测试。在排除了婴儿腹泻的常见原因后,评估通过分析粪便特征(水样、脂肪样或血性)和组织学特征(如肠活检中的绒毛到隐窝比)进行。由于消化、吸收、营养物质和电解质转运或肠内分泌细胞发育或功能缺陷而导致的 CODEs 婴儿具有正常的绒毛到隐窝比;由于肠细胞结构或免疫介导的疾病导致异常的绒毛到隐窝比和形态。在评估的早期阶段进行全外显子组和基因组测序可以减少明确诊断 CODEs 所需的时间,或者导致鉴定与这些肠病相关的新变异。基因突变的功能影响可以在肠类器官或诱导多能干细胞等模型系统中进行分析,并得益于基因编辑程序的最新进展。对新的 CODE 疾病的特征描述和研究将改善患者的管理,并增进我们对肠上皮细胞和其他肠黏膜细胞的理解。